Moderate Hypofractionation in Curative Therapy of Prostate Cancer: Correlation of Dosimetry with Toxicity

被引：0
|
作者：
Goyal, S. [1 ]
Kataria, V. [1 ]
Periasamy, K. [1 ]
Mehta, A. [1 ]
Madan, R. [1 ]
Khosla, D. [1 ]
机构：
[1] Post Grad Inst Med Educ & Res, Chandigarh, India
来源：
MEDICAL PHYSICS | 2024年 / 51卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
TU300-GPD(
引用
收藏
页码：7806 / 7806
页数：1
相关论文
共 50 条
  • [21] Are We Now Able to Define Guidelines for Moderate Hypofractionation in Prostate Cancer Radiation Therapy?
    Brenner, David J.
    Hall, Eric J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (04): : 871 - 873
  • [22] Prostate cancer hypofractionation: impact of prostate gland dimension in genitourinary toxicity
    Fersino, S.
    Levra, N. Giaj
    Mazzola, R.
    Fiorentino, A.
    Ricchetti, F.
    Ruggieri, R.
    Alongi, F.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S624 - S625
  • [23] Dose constraints validation in moderate hypofractionation in localized prostate cancer
    Maldonado, X.
    Altabas, M.
    Garre, J.
    Vazquez, M.
    Magrina, S.
    Delgado, A.
    Docampo, N.
    Geng, A.
    Hermida, M.
    Sanchez-Artuno, D.
    Giralt, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1113 - S1114
  • [24] Moderate or extreme hypofractionation and localized prostate cancer: The times are changing
    Krhili, S. Line
    Crehange, G.
    Albert-Dufrois, H.
    Guimas, V.
    Minsat, M.
    Supiot, S.
    CANCER RADIOTHERAPIE, 2019, 23 (6-7): : 503 - 509
  • [25] Moderate hypofractionation radiotherapy with helical tomotherapy (HT) for prostate cancer
    Ferrera, G.
    Mortellaro, G.
    Caminiti, G.
    Mazzola, R.
    Spera, A.
    Grillo, A.
    Di Paola, G.
    Cucchiara, T.
    Sciume, F.
    Messana, D.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S91 - S92
  • [26] Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial
    Pollack, A
    Hanlon, AL
    Horwitz, EM
    Feigenberg, SJ
    Konski, AA
    Movsas, B
    Greenberg, RE
    Uzzo, RG
    Ma, CMC
    McNeeley, SW
    Buyyounouski, MK
    Price, RA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (02): : 518 - 526
  • [27] Radiation Therapy in Prostate Cancer Defining the Benefit of Hypofractionation
    Shah, Chirag
    Kotecha, Rupesh
    Stephans, Kevin
    Tendulkar, Rahul
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (04): : 327 - 328
  • [28] Energy use in moderate hypofractionation and stereotactic body radiotherapy for prostate cancer
    Laughlin, Brady S.
    Anderson, Justin D.
    Hobbis, Dean
    Armstrong, Michael
    Vargas, Carlos E.
    Rong, Yi
    Yu, Nathan Y.
    BJU INTERNATIONAL, 2023, 132 (06) : 648 - 650
  • [29] Hypofractionation for Prostate Cancer
    Ritter, Mark
    Forman, Jeffrey
    Kupelian, Patrick
    Lawton, Colleen
    Petereit, Daniel
    CANCER JOURNAL, 2009, 15 (01): : 1 - 6
  • [30] Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study
    Kliton, Jorgo
    Polgar, Csaba
    Major, Tibor
    Stelczer, Gabor
    Herein, Andras
    Pocza, Tamas
    Gesztesi, Laszlo
    Agoston, Peter
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 905 - 912
12345